APA Corporation stock trades at EUR 40.05 late Friday
ATS stock trades at 15.20 euros ahead of results
S&P / TSX Composite Ends November 6 Down 0.21%
Allianz Braces for November 12 as Margin Test Collides With Metzler's Bullish Call
BIST 100 closes Friday at 11,482.60 points, up 1.32%
Charter Communications stock trades at EUR 106.01 late Friday
Geron stock trades at EUR 0.88 on Lang & Schwarz Friday
Arbor Realty Trust stock trades at EUR 1.44 late Friday
Accendra Health stock faces guidance reset after Q3 loss
Lennar stock trades at EUR 79.92 late in Europe
Fiserv stock holds 2026 outlook after $6.45 billion charge
Emera stock trades at 45.34 euros late Friday
Curis stock: Q3 results and webcast set for November 12
Sirius XM stock draws fresh focus after Berkshire buys more shares
Senseonics stock trades at EUR 7.73 after Freedom study launch
Kraken Robotics stock follows $102 million order update
Hensoldt's 77% Order Surge Wins Analyst Support, but Cash Conversion Holds the Key
Jinko Holdings stock gains as Q3 margin rebounds to 12.3%
IES Holdings stock stays in focus in Friday evening trading
Casey's General Stores stock trades at EUR 617.70 late Friday
Chipotle stock faces margin pressure despite Q3 growth
Fluence Energy stock trades at 4.76 euros late Friday
NextDecade stock trades at 5.24 euros late Friday
Novavax stock: Sanofi milestone lifts 2026 revenue outlook
Medical Properties Trust stock trades at 1.63 euros late Friday
Elanco stock: 2026 outlook raised after third-quarter growth
Iovance Biotherapeutics stock trades at EUR 7.20 Friday evening
Nu Holdings stock faces 6.7% options move ahead of earnings
AECOM stock trades at EUR 59.75 in Friday's late session
Campbell Soup stock trades at EUR 20.72 on Friday evening
Sunrun stock posts Q3 profit as 2026 cash outlook narrows
Grab stock draws focus after Q3 growth and higher 2026 outlook
Copart stock draws focus as ACV deal broadens auction platform
German American Bancorp stock trades at EUR 45.00 late Friday
CVR Energy stock reports record Q3 as refinery deal advances
Exelixis stock: Q3 revenue rises as zanzalintinib advances